methylene blue has been researched along with mesna in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aeschlimann, C; Cerny, T; Küpfer, A; Schefer, H | 1 |
| Foxall, PJ; Hartley, JM; Lapsley, M; Neild, GH; Nicholson, JK; Singer, JM; Souhami, RL | 1 |
| Stewart, SL | 1 |
1 trial(s) available for methylene blue and mesna
| Article | Year |
|---|---|
Comparative pharmacokinetics of oral and intravenous ifosfamide/mesna/methylene blue therapy.
Topics: Administration, Oral; Adult; Aged; Antidotes; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Biological Availability; Expectorants; Female; Humans; Ifosfamide; Injections, Intravenous; Male; Mesna; Methylene Blue; Middle Aged | 1998 |
2 other study(ies) available for methylene blue and mesna
| Article | Year |
|---|---|
Urinary proton magnetic resonance studies of early ifosfamide-induced nephrotoxicity and encephalopathy.
Topics: Adult; Amino Acids; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Brain Diseases; Dicarboxylic Acids; Humans; Ifosfamide; Kidney Cortex; Kidney Diseases; Kidney Function Tests; Kidney Medulla; Magnetic Resonance Spectroscopy; Mesna; Methylene Blue; Molecular Weight; Neoplasms; Protons; Retinol-Binding Proteins; Urinalysis | 1997 |
Postchemotherapy confusion.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Female; Humans; Ifosfamide; Mesna; Methylene Blue; Neurotoxicity Syndromes; Oncology Nursing; Osteosarcoma | 2001 |